Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The value of the multiple sclerosis specialist nurse with respect to prevention of unnecessary emergency admission.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE.
Modeling the variability in brain morphology and lesion distribution in multiple sclerosis by deep learning.
Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions.
Use of Intravenous Immunoglobulin in the Treatment of Immune-Mediated Demyelinating Diseases of the Nervous System.
Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
Human papillomavirus vaccination, induced autoimmunity, and neuromyelitis optica.
[Treatment of spasticity in multiple sclerosis: new perspectives regarding the use of cannabinoids].
Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders.
The potential for new therapeutic approaches: Global research collaboration examines multiple pathways of neuroprotection in Huntington disease
Cortical lesion load correlates with diffuse injury of multiple sclerosis normal appearing white matter.
Update on biomarkers in neuromyelitis optica.
Severe septal panniculitis in a multiple sclerosis patient treated with interferon-beta.
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice.
1,25-Dihydroxyvitamin D3 Facilitates M2 Polarization and Upregulates TLR10 Expression on Human Microglial Cells.
The risk of Bipolar Disorders in Multiple Sclerosis.
Cognitive and Behavioral Outcomes in Individuals With a History of Acute Disseminated Encephalomyelitis (ADEM).
Axonal transport analysis using Multitemporal Association Tracking.
Subcortical and Cortical Gray Matter Atrophy in a Large Sample of Patients with Clinically Isolated Syndrome and Early Relapsing-Remitting Multiple Sclerosis.
A Study of the Safety and Efficacy of ONO-4641 in Patients With Relapsing-Remitting Multiple Sclerosis (DreaMS)
Type I IFN-mediated regulation of IL-1 production in inflammatory disorders.
The geometric and spatial constraints of the microenvironment induce oligodendrocyte differentiation.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Alteration of CD1 expression in multiple sclerosis.

Pages